FDA’s Botched Review of Moderna’s Flu mRNA Vaccine
When the FDA licensed Moderna’s new mRNA flu vaccine [earlier this month], legacy media coverage focused almost exclusively on efficacy. The pivotal trial reported that the vaccine was “26.6% more effective” than a conventional flu vaccine at preventing protocol-defined influenza-like illness. What received far less scrutiny was a much more serious problem in the trial […]
mRNA, Spike Proteins Persist in the Human Body for More Than 3.5 Years After COVID-19 Shots
A newly published case report in Medical Research Archives found that vaccine-derived synthetic mRNA, spike protein and plasmid DNA sequences persisted in the blood and tissue of a 55-year-old man more than three years after his last Pfizer mRNA COVID-19 shot, with some components detected beyond the 3.5-year mark. The case report, published July 1, […]
Despite Safety Concerns, FDA Approves Moderna’s mRNA Flu Shot
On Aug. 5, 2026, the U.S. Food and Drug Administration (FDA) approved Moderna’s seasonal flu shot, mFLUSIVA (mRNA-1010), making it the first messenger RNA platform for seasonal influenza in the United States. The decision permits health care providers to use mRNA technology for annual influenza vaccination in eligible age groups.1 FDA regulators approved mFLUSIVA to […]
WHO Report Projects Cancer Cases Will Nearly Double Worldwide by 2050
The World Health Organization (WHO) Global Status Report on Cancer 2026, released on July 8, 2026, projects that, without urgent action, new annual cancer cases will nearly double, from the current 20.6 million to nearly 35 million by 2050. While heart disease remains the leading cause of death worldwide, cancer ranks second. The WHO attributes […]
FDA Flags Manufacturing Issues at Biologics Facility in India
The U.S. Food and Drug Administration (FDA) has flagged violations at a large manufacturing facility in India, which distributes biologics and drugs in the United States. The FDA issued a Form 483 with seven inspection observations following a recent review of Dr. Reddy’s Laboratories, a biologics manufacturing facility in Bachupally, Hyderabad, India. The agency has […]
First Trimester COVID-19 Shot Linked to Birth Defects in New Registry Study
A new registry-based cohort study out of Iran published in Sage Journals on June 15, 2026, has found a higher incidence of congenital anomalies, or birth defects, in babies born to women who received a COVID-19 shot within the first trimester of pregnancy compared with those who did not get vaccinated or were vaccinated after […]